Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules
暂无分享,去创建一个
J. Herman | M. Brock | Jingqun Tang | Xiang Wang | Wenliang Liu | F. Yu | Fang Wu | A. Hulbert | W. Yin | Chen Chen | Mingjiu Chen | Xiaojie Huang | M. Peng | Xia Wu
[1] H. Nielsen,et al. Genome-wide cell-free DNA fragmentation in patients with cancer , 2019, Nature.
[2] W. Liang,et al. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA) , 2019, Theranostics.
[3] P. Massion,et al. Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[4] Alexander Y. Trick,et al. Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study , 2019, Clinical Cancer Research.
[5] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[6] The Lancet Respiratory Medicine. Lung cancer screening in Europe: hurdles to overcome. , 2018, The Lancet. Respiratory medicine.
[7] Y. Dor,et al. Principles of DNA methylation and their implications for biology and medicine , 2018, The Lancet.
[8] Charles Swanton,et al. Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection , 2018, Nature Reviews Clinical Oncology.
[9] Tim De Meyer,et al. Analysis of DNA methylation in cancer: location revisited , 2018, Nature Reviews Clinical Oncology.
[10] A. Ruano-Raviña,et al. Low-dose CT for lung cancer screening. , 2018, The Lancet. Oncology.
[11] H. D. de Koning,et al. Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screening , 2018, Thorax.
[12] F. Hirsch,et al. Early detection of lung cancer by using an autoantibody panel in Chinese population , 2018, Oncoimmunology.
[13] M. Esteller,et al. Lung cancer epigenetics: From knowledge to applications. , 2017, Seminars in cancer biology.
[14] P. Huang,et al. Added Value of Computer-aided CT Image Features for Early Lung Cancer Diagnosis with Small Pulmonary Nodules: A Matched Case-Control Study. , 2018, Radiology.
[15] Matthew B Schabath,et al. Radiologic Features of Small Pulmonary Nodules and Lung Cancer Risk in the National Lung Screening Trial: A Nested Case-Control Study. , 2018, Radiology.
[16] Wei Zhang,et al. Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer , 2017, BMC Genomics.
[17] Lesley Uttley,et al. The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review , 2017, BMC Cancer.
[18] Yi-long Wu,et al. The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer , 2017, Journal of Hematology & Oncology.
[19] F. Khuri,et al. Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence , 2017, Cancer Prevention Research.
[20] C. Zahnow,et al. Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations. , 2017, Cancer cell.
[21] Sam Angiuoli,et al. Direct detection of early-stage cancers using circulating tumor DNA , 2017, Science Translational Medicine.
[22] M. Brock,et al. Non-blood circulating tumor DNA detection in cancer , 2017, Oncotarget.
[23] William A. Flavahan,et al. Epigenetic plasticity and the hallmarks of cancer , 2017, Science.
[24] F. Khuri,et al. Gene methylation biomarkers in sputum as a classifier for lung cancer risk , 2017, Oncotarget.
[25] Frank C. Detterbeck,et al. The Eighth Edition Lung Cancer Stage Classification , 2017, Chest.
[26] Y. Rozenholc,et al. Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study , 2016, PLoS medicine.
[27] J. Herman,et al. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum , 2016, Clinical Cancer Research.
[28] H. Ye,et al. Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing , 2016, Scientific Reports.
[29] Ash A. Alizadeh,et al. Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients , 2016, Nature Communications.
[30] A. Uitterlinden,et al. Genetic and environmental influences interact with age and sex in shaping the human methylome , 2016, Nature Communications.
[31] A. Jemal,et al. Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.
[32] P. Śliwiński,et al. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease , 2015, British Journal of Cancer.
[33] J. Herman,et al. Functional Identification of Cancer-Specific Methylation of CDO1, HOXA9, and TAC1 for the Diagnosis of Lung Cancer , 2014, Clinical Cancer Research.
[34] Ash A. Alizadeh,et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage , 2013, Nature Medicine.
[35] Tza-Huei Wang,et al. Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[36] K. Pantel,et al. Circulating tumor cells and circulating tumor DNA. , 2012, Annual review of medicine.
[37] W. Rom,et al. Molecular Analysis of Plasma DNA for the Early Detection of Lung Cancer by Quantitative Methylation-Specific PCR , 2010, Clinical Cancer Research.
[38] Yi Zhang,et al. Single-tube analysis of DNA methylation with silica superparamagnetic beads. , 2010, Clinical chemistry.
[39] Steven S. Chang,et al. Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma , 2008, Clinical Cancer Research.
[40] F. Gilliland,et al. Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer Risk , 2005, Clinical Cancer Research.
[41] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[42] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.